Drug Type siRNA |
Synonyms |
Mechanism SARS coronavirus 2 ORF1Ab inhibitors(SARS coronavirus 2 ORF1Ab inhibitors), SARS-CoV-2 N protein inhibitors(SARS-CoV-2 N protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | IND Application | US | - |